Early access
Sign in
Taking people in SpainPhase 1

Tests JNJ-95437446 in people with advanced solid tumors that returned or worsened

Tests JNJ-95437446 in adults with advanced lung, colorectal or head and neck cancer.

Key facts

Who runs it
Janssen Cilag International
Where
Barcelona and Madrid, SpainSee the 4 sites
Registry title
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors
Status
Recruiting
Phase
Phase 1
People taking part
52 people, planned
Started
3 Nov 2025
Expected to end
18 Nov 2027
Type of study
Interventional
Record updated
8 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced non-small cell lung cancer, colorectal cancer or head and neck squamous cell cancer that came back or grew after standard treatment.

Age
18 years or older
Sex
Men and women
Disease stage
Locally advanced or metastatic NSCLC, CRC or HNSCC that has recurred or progressed after prior standard of care therapy
Earlier treatment
Must have had standard of care therapy before, and the cancer came back or grew

Where in Spain

  • Hospital Universitari Vall d'HebronBarcelona, SpainTaking people
  • Hospital Universitario 12 de OctubreMadrid, SpainTaking people
  • Hospital Universitario Fundación Jiménez DíazMadrid, SpainTaking people
  • Hospital Universitario HM SanchinarroMadrid, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests JNJ-95437446 in people with advanced solid tumors that returned or worsenedGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
8 June 2026